Logo image of BZUN

BAOZUN INC-SPN ADR (BZUN) Stock Fundamental Analysis

NASDAQ:BZUN - Nasdaq - US06684L1035 - ADR - Currency: USD

3.07  -0.02 (-0.65%)

After market: 3.012 -0.06 (-1.89%)

Fundamental Rating

3

BZUN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 28 industry peers in the Broadline Retail industry. BZUN may be in some trouble as it scores bad on both profitability and health. BZUN is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year BZUN has reported negative net income.
BZUN had negative earnings in 4 of the past 5 years.
Of the past 5 years BZUN 4 years had a positive operating cash flow.
BZUN Yearly Net Income VS EBIT VS OCF VS FCFBZUN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M -600M

1.2 Ratios

BZUN's Return On Assets of -1.87% is in line compared to the rest of the industry. BZUN outperforms 42.86% of its industry peers.
BZUN has a Return On Equity (-4.74%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -1.87%
ROE -4.74%
ROIC N/A
ROA(3y)-3.64%
ROA(5y)-1.73%
ROE(3y)-9.17%
ROE(5y)-5.01%
ROIC(3y)N/A
ROIC(5y)N/A
BZUN Yearly ROA, ROE, ROICBZUN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10 -15

1.3 Margins

The Gross Margin of BZUN (73.34%) is better than 96.43% of its industry peers.
In the last couple of years the Gross Margin of BZUN has grown nicely.
The Profit Margin and Operating Margin are not available for BZUN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 73.34%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.23%
GM growth 5Y3.57%
BZUN Yearly Profit, Operating, Gross MarginsBZUN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

3

2. Health

2.1 Basic Checks

BZUN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BZUN has less shares outstanding
Compared to 5 years ago, BZUN has less shares outstanding
The debt/assets ratio for BZUN is higher compared to a year ago.
BZUN Yearly Shares OutstandingBZUN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
BZUN Yearly Total Debt VS Total AssetsBZUN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

Based on the Altman-Z score of 1.37, we must say that BZUN is in the distress zone and has some risk of bankruptcy.
BZUN has a Altman-Z score of 1.37. This is comparable to the rest of the industry: BZUN outperforms 42.86% of its industry peers.
A Debt/Equity ratio of 0.42 indicates that BZUN is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.42, BZUN is doing worse than 60.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF N/A
Altman-Z 1.37
ROIC/WACCN/A
WACC2.57%
BZUN Yearly LT Debt VS Equity VS FCFBZUN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

BZUN has a Current Ratio of 1.99. This is a normal value and indicates that BZUN is financially healthy and should not expect problems in meeting its short term obligations.
BZUN's Current ratio of 1.99 is fine compared to the rest of the industry. BZUN outperforms 67.86% of its industry peers.
BZUN has a Quick Ratio of 1.65. This is a normal value and indicates that BZUN is financially healthy and should not expect problems in meeting its short term obligations.
BZUN has a Quick ratio of 1.65. This is in the better half of the industry: BZUN outperforms 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.99
Quick Ratio 1.65
BZUN Yearly Current Assets VS Current LiabilitesBZUN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

More info and screens

3

3. Growth

3.1 Past

The earnings per share for BZUN have decreased strongly by -28.54% in the last year.
The Revenue has been growing slightly by 6.76% in the past year.
BZUN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.30% yearly.
EPS 1Y (TTM)-28.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-288.24%
Revenue 1Y (TTM)6.76%
Revenue growth 3Y0.09%
Revenue growth 5Y5.3%
Sales Q2Q%4.27%

3.2 Future

Based on estimates for the next years, BZUN will show a very strong growth in Earnings Per Share. The EPS will grow by 80.20% on average per year.
Based on estimates for the next years, BZUN will show a small growth in Revenue. The Revenue will grow by 4.43% on average per year.
EPS Next Y320.62%
EPS Next 2Y130.61%
EPS Next 3Y108.16%
EPS Next 5Y80.2%
Revenue Next Year4.5%
Revenue Next 2Y3.98%
Revenue Next 3Y4.54%
Revenue Next 5Y4.43%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BZUN Yearly Revenue VS EstimatesBZUN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B 10B
BZUN Yearly EPS VS EstimatesBZUN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 4 6 8

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

BZUN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 9.29, which indicates a very decent valuation of BZUN.
BZUN's Price/Forward Earnings ratio is rather cheap when compared to the industry. BZUN is cheaper than 82.14% of the companies in the same industry.
BZUN is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.44, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 9.29
BZUN Price Earnings VS Forward Price EarningsBZUN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

BZUN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. BZUN is cheaper than 64.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.86
BZUN Per share dataBZUN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

BZUN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BZUN's earnings are expected to grow with 108.16% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y130.61%
EPS Next 3Y108.16%

More info and screens

0

5. Dividend

5.1 Amount

BZUN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BAOZUN INC-SPN ADR

NASDAQ:BZUN (7/21/2025, 8:00:01 PM)

After market: 3.012 -0.06 (-1.89%)

3.07

-0.02 (-0.65%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)05-21 2025-05-21/bmo
Earnings (Next)08-26 2025-08-26
Inst Owners20.18%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap177.35M
Analysts83.33
Price Target3.81 (24.1%)
Short Float %4.79%
Short Ratio2.75
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)37.04%
Min EPS beat(2)31.65%
Max EPS beat(2)42.43%
EPS beat(4)2
Avg EPS beat(4)-97.01%
Min EPS beat(4)-346.95%
Max EPS beat(4)42.43%
EPS beat(8)4
Avg EPS beat(8)-168.99%
EPS beat(12)4
Avg EPS beat(12)-228.99%
EPS beat(16)6
Avg EPS beat(16)-261.31%
Revenue beat(2)1
Avg Revenue beat(2)0%
Min Revenue beat(2)-0.42%
Max Revenue beat(2)0.42%
Revenue beat(4)2
Avg Revenue beat(4)2.16%
Min Revenue beat(4)-4.21%
Max Revenue beat(4)12.85%
Revenue beat(8)3
Avg Revenue beat(8)-0.24%
Revenue beat(12)3
Avg Revenue beat(12)-1.21%
Revenue beat(16)4
Avg Revenue beat(16)-1.68%
PT rev (1m)0%
PT rev (3m)2.43%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-38.81%
EPS NY rev (1m)0%
EPS NY rev (3m)95.49%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.16%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.12%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 9.29
P/S 0.13
P/FCF N/A
P/OCF N/A
P/B 0.33
P/tB 0.41
EV/EBITDA 11.86
EPS(TTM)-0.2
EYN/A
EPS(NY)0.33
Fwd EY10.76%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS22.92
BVpS9.26
TBVpS7.55
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.87%
ROE -4.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 73.34%
FCFM N/A
ROA(3y)-3.64%
ROA(5y)-1.73%
ROE(3y)-9.17%
ROE(5y)-5.01%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.23%
GM growth 5Y3.57%
F-ScoreN/A
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF N/A
Debt/EBITDA 14.94
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.99
Quick Ratio 1.65
Altman-Z 1.37
F-ScoreN/A
WACC2.57%
ROIC/WACCN/A
Cap/Depr(3y)102.69%
Cap/Depr(5y)116.63%
Cap/Sales(3y)2.63%
Cap/Sales(5y)2.69%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-288.24%
EPS Next Y320.62%
EPS Next 2Y130.61%
EPS Next 3Y108.16%
EPS Next 5Y80.2%
Revenue 1Y (TTM)6.76%
Revenue growth 3Y0.09%
Revenue growth 5Y5.3%
Sales Q2Q%4.27%
Revenue Next Year4.5%
Revenue Next 2Y3.98%
Revenue Next 3Y4.54%
Revenue Next 5Y4.43%
EBIT growth 1Y26.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year342.97%
EBIT Next 3Y78.08%
EBIT Next 5Y55.39%
FCF growth 1Y-149.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-77.46%
OCF growth 3YN/A
OCF growth 5Y-19.64%